Track every registration update on the InsiderAlpha IPO tracker.
Updated Jul 16, 2026 · Last SEC filing 2026-07-10
Evommune, Inc. (EVMN) has filed 18 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-10. 3 Form 8-K material event filings were reported by EVMN in the last 90 days. 6 Form 144 notices of proposed sale were filed for EVMN stock. InsiderAlpha tracks every EVMN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0002044725 |
|---|
| Form 4 filings (90d) | 18 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 6 |
| Latest Form 4 filing | 2026-07-10 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carver Kyle | Chief Financial Officer | P — Open-market purchase | 1.0K | $13.26 | $13K | SEC | |
| Kirsch Arthur S | Insider | P — Open-market purchase | 10.0K | $13.30 | $133K | SEC | |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | S — Open-market sale | 1.5K | $22.50 | $33K | SEC | |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | M — Option exercise | 1.5K | $3.84 | $6K | SEC | |
| Drew Janice Suzann | Chief of Dev. Operations | S — Open-market sale | 20.0K | $22.63 | $453K | SEC | |
| Drew Janice Suzann | Chief of Dev. Operations | M — Option exercise | 16.2K | $2.99 | $48K | SEC | |
| Drew Janice Suzann | Chief of Dev. Operations | M — Option exercise | 3.8K | $3.84 | $15K | SEC | |
| Pena Luis C. | President & CEO | S — Open-market sale | 7.4K | $22.71 | $169K | SEC | |
| Cohen David E | Insider | S — Open-market sale | 5.5K | $20.21 | $110K | SEC | |
| Cohen David E | Insider | S — Open-market sale | 600 | $21.38 | $13K | SEC | |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | M — Option exercise | 13.5K | $3.84 | $52K | SEC | |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | S — Open-market sale | 16.7K | $22.74 | $379K | SEC | |
| Pena Luis C. | President & CEO | S — Open-market sale | 16.8K | $22.74 | $382K | SEC | |
| Moss Gregory S. | Chief Business & Legal Officer | M — Option exercise | 14.2K | $1.71 | $24K | SEC | |
| Carver Kyle | Chief Financial Officer | S — Open-market sale | 18.2K | $22.84 | $415K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Evommune, Inc. (EVMN). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Patel Jeegar Pravinkumar | 7 | $471K |
| Drew Janice Suzann | 6 | $516K |
| Carver Kyle | 5 | $473K |
| Moss Gregory S. | 4 | $349K |
| Cohen David E | 3 | $123K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in EVMN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live EVMN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.